Brain Perfusion and Hemodynamic Stability in Patients Undergoing Radiofrequency Ablation of Ventricular Tachycardia
Status: | Enrolling by invitation |
---|---|
Conditions: | Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | July 2012 |
End Date: | August 2016 |
Assessment of Intracardiac and Surgace Electrogram Characteristics Correlated to Brain Perfusion and Hemodynamic Stability in Patients Undergoing Radiofrequency Ablation of Ventricular Tachycardia
Ventricular tachycardia (VT) is a life-threatening, fast heart rhythm that starts in the
lower chambers of the heart (the ventricles). This fast heartbeat is caused by abnormal
electrical pathways located in the heart tissue. A standard procedure called a catheter
ablation has been used for several years to help correct these abnormal pathways and, in
some cases, improve or even eliminate the ventricular tachycardia.
During a VT ablation it is routine to monitor your vital signs (blood pressure, heart rate,
and oxygen saturation in your blood). If you choose to participate in this study we will
also monitor your cerebral oximetry, the amount of blood flow and oxygen saturation to your
brain during the ablation.
By doing this study, we hope to have a better understanding of patients' blood and oxygen
flow to their brain during an episode of Ventricular Tachycardia (VT).
lower chambers of the heart (the ventricles). This fast heartbeat is caused by abnormal
electrical pathways located in the heart tissue. A standard procedure called a catheter
ablation has been used for several years to help correct these abnormal pathways and, in
some cases, improve or even eliminate the ventricular tachycardia.
During a VT ablation it is routine to monitor your vital signs (blood pressure, heart rate,
and oxygen saturation in your blood). If you choose to participate in this study we will
also monitor your cerebral oximetry, the amount of blood flow and oxygen saturation to your
brain during the ablation.
By doing this study, we hope to have a better understanding of patients' blood and oxygen
flow to their brain during an episode of Ventricular Tachycardia (VT).
Inclusion Criteria:
- Able to give informed consent
- Have implantable defibrillator in-situ and are undergoing ablation procedure for
ventricular tachycardia
Exclusion Criteria:
- Patients who have been hypotensive with systolic blood pressure of < 80mm Hg prior to
procedure
- Cerebral event as defined by Cerebrovascular Accident or Transient Ischemia Attack
within six months prior to procedure
We found this trial at
1
site
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
Click here to add this to my saved trials